Literature DB >> 18852443

Update on blepharospasm: report from the BEBRF International Workshop.

Mark Hallett1, Craig Evinger, Joseph Jankovic, Mark Stacy.   

Abstract

This review updates understanding and research on blepharospasm, a subtype of focal dystonia. Topics covered include clinical aspects, pathology, pathophysiology, animal models, dry eye, photophobia, epidemiology, genetics, and treatment. Blepharospasm should be differentiated from apraxia of eyelid opening. New insights into pathology and pathophysiology are derived from different types of imaging, including magnetic resonance studies. Physiologic studies indicate increased plasticity and trigeminal sensitization. While botulinum neurotoxin injections are the mainstay of therapy, other therapies are on the horizon.

Entities:  

Mesh:

Year:  2008        PMID: 18852443      PMCID: PMC2676990          DOI: 10.1212/01.wnl.0000327601.46315.85

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  51 in total

1.  Cortical control of voluntary blinking: a transcranial magnetic stimulation study.

Authors:  Y H Sohn; B Voller; M Dimyan; A St Clair Gibson; T Hanakawa; F E Leon-Sarmiento; H Y Jung; M Hallett
Journal:  Clin Neurophysiol       Date:  2004-02       Impact factor: 3.708

Review 2.  Central nervous system mechanisms in Sjögren's syndrome.

Authors:  O P van Bijsterveld; A A Kruize; R L A W Bleys
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

3.  Age at onset as a factor in determining the phenotype of primary torsion dystonia.

Authors:  S O'Riordan; D Raymond; T Lynch; R Saunders-Pullman; S B Bressman; L Daly; M Hutchinson
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

4.  Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Authors:  Raif Cakmur; Vesile Ozturk; Fatma Uzunel; Beril Donmez; Fethi Idiman
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

5.  Positron emission tomography scanning in essential blepharospasm.

Authors:  John B Kerrison; Jack L Lancaster; Frank E Zamarripa; Londe A Richardson; John C Morrison; David E E Holck; Kurt W Andreason; Sean M Blaydon; Peter T Fox
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

6.  Brainstem pathology in DYT1 primary torsion dystonia.

Authors:  Kevin St P McNaught; Alexander Kapustin; Tehone Jackson; Toni-Ann Jengelley; Ruth Jnobaptiste; Pullanipally Shashidharan; Daniel P Perl; Pedro Pasik; C Warren Olanow
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

7.  Action spectrum for photophobia.

Authors:  James M Stringham; Kenneth Fuld; Adam J Wenzel
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2003-10       Impact factor: 2.129

8.  Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.

Authors:  P Lamberti; M De Mari; A Zenzola; M S Aniello; G Defazio
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

9.  Bilateral pallidal stimulation for blepharospasm-oromandibular dystonia (Meige syndrome).

Authors:  Hans-Holger Capelle; Ralf Weigel; Joachim K Krauss
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

10.  Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.

Authors:  Dana B Hancock; Eden R Martin; Jeffrey M Stajich; Rita Jewett; Mark A Stacy; Burton L Scott; Jeffery M Vance; William K Scott
Journal:  Arch Neurol       Date:  2007-04
View more
  61 in total

1.  Clinical features of patients with blepharospasm: a report of 240 patients.

Authors:  E L Peckham; G Lopez; E A Shamim; S Pirio Richardson; S Sanku; R Malkani; M Stacy; P Mahant; A Crawley; A Singleton; M Hallett
Journal:  Eur J Neurol       Date:  2011-03       Impact factor: 6.089

Review 2.  Secondary blepharospasm associated with structural lesions of the brain.

Authors:  M A Khooshnoodi; S A Factor; H A Jinnah
Journal:  J Neurol Sci       Date:  2013-06-06       Impact factor: 3.181

3.  Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study.

Authors:  Jing Yang; ChunYan Luo; Wei Song; Qin Chen; Ke Chen; XuePing Chen; XiaoQi Huang; QiYong Gong; HuiFang Shang
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 4.849

4.  Development and validation of a clinical scale for rating the severity of blepharospasm.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Glenn T Stebbins; Angelo F Gigante; Gina Ferrazzano; Antonella Conte; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Mov Disord       Date:  2015-04       Impact factor: 10.338

5.  Successful Treatment of Blepharospasm by Pallidal Neurostimulation.

Authors:  Ana Filipa Santos; Andreia Veiga; Luís Augusto; Rui Vaz; Maria José Rosas; Jens Volkmann
Journal:  Mov Disord Clin Pract       Date:  2016-01-05

Review 6.  Shedding light on photophobia.

Authors:  Kathleen B Digre; K C Brennan
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

7.  Diffusion tensor imaging in blepharospasm and blepharospasm-oromandibular dystonia.

Authors:  Jing Yang; ChunYan Luo; Wei Song; XiaoYan Guo; Bi Zhao; XuePing Chen; XiaoQi Huang; QiYong Gong; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-05-03       Impact factor: 4.849

8.  Trigeminal high-frequency stimulation produces short- and long-term modification of reflex blink gain.

Authors:  Michael Ryan; Jaime Kaminer; Patricia Enmore; Craig Evinger
Journal:  J Neurophysiol       Date:  2013-11-27       Impact factor: 2.714

9.  Development and validation of a clinical guideline for diagnosing blepharospasm.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Alfredo Berardelli
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

10.  Trigeminal pathways for hypertonic saline- and light-evoked corneal reflexes.

Authors:  M Rahman; K Okamoto; R Thompson; D A Bereiter
Journal:  Neuroscience       Date:  2014-07-31       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.